ONCE – FDA schedules October 12 Cellular, Tissue, and Gene Therapies Advisory Committee meeting to discuss and make recommendations on the safety and effectiveness of biologics license application for voretigene neparvovec.
- Forums
- ASX - By Stock
- BLT
- if not now then when?
if not now then when?, page-14
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)